老年原发性肝癌患者经导管肝动脉化疗栓塞治疗特点

原发性肝癌（primary hepatocellular carcinoma，PHC）是常见恶性实体肿瘤，PHC的高发年龄段为40岁～60岁，但随着我国人口的老龄化趋势，老年PHC患者比例有所上升。由于老年人各组织、器官的解剖、生理状况不同于中青年人，故在介入治疗上有其特殊性。本文结合我院自1999年1月～2006年12月收治的年龄≥60岁的曾经接受过经导管肝动脉化疗栓塞（transcatheterarterialchemoembolization，TACE）治疗的88例肝癌患者完整临床资料，探讨老年PHC患者的TACE特点。

Characteristics of Elderly Patients with Primary Hepatocellular Carcinoma Transcatheter Arterial Chemoembolization Therapy

Primary hepatocellular carcinoma is one kind of common malignant tumor, the prevalence rate of PHC is high in 40～60 years old people, but along with our country population aging tendency, The PHC patients of old people proportion has the rise. The interventional therapy of senior citizen has its specificity because their organization and physiological condition are different from the young people. In this paper we analyze clinical features of primary hepatocellular carcinoma in elderly patients by summarizing clinical data from January 1999 to December 2006.